The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients

被引：6
|
作者：
El Desoky, Ehab S. [1 ]
Abdelhafez, Alaa T. [1 ]
Cusato, Jessica [2 ]
Kamel, Sherif I. [3 ]
Hussein, Abeer M. R. [1 ]
De Nicolo, Amedeo [2 ]
Di Perri, Giovanni [2 ]
D'Avolio, Antonio [2 ]
机构：
[1] Assiut Univ, Dept Pharmacol, Fac Med, Assiut, Egypt
[2] Univ Turin, Amedeo di Savoia Hosp, Infect Dis Unit, Dept Med Sci, Turin, Italy
[3] Assiut Univ, Dept Trop Med & Gastroenterol, Fac Med, Assiut, Egypt
来源：
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2017年 / 44卷 / 09期
关键词：
anaemia; ITPA; pharmacogenetics; ribavirin; SLC28A3; SLC29A1; HCV PATIENTS; INFECTION; VARIANTS; SERUM;
D O I：
10.1111/1440-1681.12786
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Few data are available concerning the roles of polymorphisms of inosine triphosphatase (ITPA) gene and ribavirin (RBV) transporter genes in the prediction of RBV-induced anaemia among Egyptians with chronic hepatitis C (CHC). Genotyping of three ITPA gene variants and two variants of RBV transporter genes has been performed in 123 patients under pegylated interferon-/ribavirin treatment. The baseline haemoglobin and ITPA rs1127354 CA/AA have been found as predictors of anaemia at 4, 8 and 12weeks of RBV therapy. In addition, ITPA rs7270101 AC/CC and age predicted anaemia after 12weeks of therapy. In conclusion, the ITPA variant rs1127354C>A significantly predict RBV-induced anaemia during the first 3months of treatment and it is recommended to be assessed before RBV administration.
引用
收藏
页码：965 / 968
页数：4
相关论文
共 50 条
  • [31] An Index to Predict Ribavirin-Induced Anemia in Asian Patients With Chronic Genotype 1 Hepatitis C
    Chen, Sheng-Hung
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Li, Yu-Fen
    Chuang, Po-Heng
    Chen, Ching-Hsiang
    HEPATITIS MONTHLY, 2015, 15 (03)
  • [32] ITPA genotype strongly protects from ribavirin-induced haemolytic anaemia: analysis from the CHARIOT study
    Holmes, Jacinta A.
    Bonanzinga, Sara
    Roberts, Stuart
    Sievert, William
    Dore, Gregory
    Mccaughan, Geoffrey
    Crawford, Darrell H.
    Cheng, Wendy
    Weltman, Martin D.
    Matthews, Gail
    Visvanathan, Kumar
    Desmond, Paul
    Bowden, D. Scott
    Thompson, Alex
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 168 - 168
  • [33] Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients
    Nishimura, Takashi
    Osaki, Rie
    Shioya, Makoto
    Imaeda, Hirotsugu
    Aomatsu, Tomoki
    Takeuchi, Takayuki
    Okumura, Yoshiaki
    Fujiyama, Yoshihide
    Andoh, Akira
    MOLECULAR MEDICINE REPORTS, 2012, 5 (02) : 517 - 520
  • [34] Prediction for Severity of Ribavirin-induced Anemia by ITPA Enzyme Activity and ATP Concentration in Human Erythrocyte
    Tanaka, Yoichi
    Yokomori, Hiroaki
    Oda, Masaya
    Ando, Wataru
    Komiyama, Takako
    HEPATOLOGY, 2013, 58 : 1130A - 1130A
  • [35] Ribavirin-Induced Anemia in Hepatitis C Virus Patients Undergoing Combination Therapy
    Krishnan, Sheeja M.
    Dixit, Narendra M.
    PLOS COMPUTATIONAL BIOLOGY, 2011, 7 (02)
  • [36] Interferon and ribavirin-induced autoimmune hypothyroidism: A prospective study of male patients with chronic hepatitis C.
    Bini, EJ
    Mehandru, S
    HEPATOLOGY, 2002, 36 (04) : 599A - 599A
  • [37] Metabolome Analysis of Erythrocytes from Patients with Chronic Hepatitis C Reveals the Etiology of Ribavirin-Induced Hemolysis
    Karasawa, Tetsuru
    Saito, Takafumi
    Ueno, Yoshiyuki
    Sugimoto, Masahiro
    Soga, Tomoyoshi
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (11): : 1575 - 1577
  • [38] ITPA polymorphisms are associated with hemoglobin decline during pegylated interferon and ribavirin therapy in chronic hepatitis C
    Maan, Raoel
    van der Meer, Adriaan J.
    Brouwer, Willem Pieter
    Sonneveld, Milan J.
    Roomer, Robert
    van der Eijk, Annemiek A.
    Groothuismink, Zwier M.
    Hansen, Bettina E.
    Janssen, Harry L.
    Boonstra, Andre
    de Knegt, Robert J.
    HEPATOLOGY, 2013, 58 : 1117A - 1118A
  • [39] ITPA polymorphisms are predictors of anemia but no contribution to outcomes in chronic hepatitis C patients who treated with interferon plus ribavirin
    Chi, Xiumei
    Wang, Mo-li
    Pan, Yu
    Jiang, Jing
    Yan, Hongqing
    Wu, Ruihong
    Wang, Xiaomei
    Niu, Junqi
    HEPATOLOGY, 2015, 62 : 800A - 800A
  • [40] Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype
    Peltenburg, Nicole Chantal
    Bakker, Jaap A.
    Vroemen, Wim H. M.
    de Knegt, Robert J.
    Leers, Mathie P. G.
    Bierau, Jorgen
    Verbon, Annelies
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (12) : 2021 - 2029
12345